XML 10 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 177,134 $ 188,657
Investment securities, available-for-sale 323,808 250,208
Accounts receivable, net 103,698 98,267
Interest and other receivables 6,695 4,083
Inventory 71,525 35,819
Prepaid expenses 46,056 39,091
Total current assets 728,916 616,125
Property and equipment, net 4,144 4,612
Operating lease right-of-use assets 52,390 51,855
Intangible assets, net 107,859 65,490
Restricted cash 5,770 5,770
Long-term inventory 14,544 4,628
Other assets 476 476
Total assets 914,099 748,956
Liabilities and stockholders’ equity    
Accounts payable 19,882 17,543
Accrued liabilities 317,969 236,711
Total current liabilities 337,851 254,254
Operating lease liabilities 47,186 47,800
Other long-term liabilities 12,362 15,147
Total liabilities 397,399 317,201
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at June 30, 2024 and December 31, 2023; no shares issued and outstanding at June 30, 2024 and December 31, 2023 0 0
Common stock, $0.0001 par value; 225,000,000 shares authorized at June 30, 2024 and December 31, 2023; 165,853,301 shares and 164,650,219 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 16 16
Additional paid-in capital 2,897,916 2,862,552
Accumulated deficit (2,380,893) (2,430,837)
Accumulated other comprehensive (loss) income (339) 24
Total stockholders’ equity 516,700 431,755
Total liabilities and stockholders’ equity $ 914,099 $ 748,956